Regranex, a Johnson & Johnson foot gel used by diabetics, may increase their risk of cancer and death. A study of the gel found an increase in the number of cancer deaths among patients who had been prescribed the gel three or more times.
Regranex is used to treat leg and foot wounds. Diabetic patients are especially susceptible to developing leg and foot wounds.
A spokesperson for Johnson & Johnson said the company was working with the FDA and that Regranex is safe when used as directed.
* Reuters March 27, 2008